Summit Investment Advisors Inc. decreased its holdings in shares of Genpact Limited (NYSE:G – Free Report) by 3.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 32,498 shares of the business services provider’s stock after selling 1,133 shares during the quarter. Summit Investment Advisors Inc.’s holdings in Genpact were worth $1,396,000 at the end of the most recent quarter.
A number of other large investors have also recently bought and sold shares of G. Atlas Capital Advisors Inc. grew its position in shares of Genpact by 55.8% during the fourth quarter. Atlas Capital Advisors Inc. now owns 603 shares of the business services provider’s stock worth $26,000 after acquiring an additional 216 shares during the last quarter. CIBC Asset Management Inc grew its position in Genpact by 5.5% in the 4th quarter. CIBC Asset Management Inc now owns 5,692 shares of the business services provider’s stock worth $244,000 after purchasing an additional 297 shares during the last quarter. Tealwood Asset Management Inc. increased its stake in shares of Genpact by 1.4% in the fourth quarter. Tealwood Asset Management Inc. now owns 24,658 shares of the business services provider’s stock valued at $1,059,000 after purchasing an additional 339 shares during the period. UMB Bank n.a. raised its holdings in shares of Genpact by 55.7% during the fourth quarter. UMB Bank n.a. now owns 1,210 shares of the business services provider’s stock valued at $52,000 after buying an additional 433 shares during the last quarter. Finally, OneAscent Wealth Management LLC boosted its position in shares of Genpact by 5.5% during the fourth quarter. OneAscent Wealth Management LLC now owns 8,380 shares of the business services provider’s stock worth $360,000 after buying an additional 439 shares during the period. Institutional investors own 96.03% of the company’s stock.
Genpact Price Performance
Shares of NYSE G opened at $47.76 on Thursday. Genpact Limited has a twelve month low of $30.23 and a twelve month high of $56.76. The company has a current ratio of 2.16, a quick ratio of 1.85 and a debt-to-equity ratio of 0.50. The firm has a 50-day moving average of $50.80 and a two-hundred day moving average of $45.92. The company has a market capitalization of $8.39 billion, a price-to-earnings ratio of 16.82, a PEG ratio of 1.84 and a beta of 1.06.
Genpact Increases Dividend
The business also recently announced a quarterly dividend, which was paid on Wednesday, March 26th. Investors of record on Tuesday, March 11th were issued a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.42%. This is a boost from Genpact’s previous quarterly dividend of $0.15. The ex-dividend date of this dividend was Tuesday, March 11th. Genpact’s payout ratio is presently 23.94%.
Wall Street Analysts Forecast Growth
Several brokerages have weighed in on G. Jefferies Financial Group raised Genpact from a “hold” rating to a “buy” rating and lifted their target price for the company from $44.00 to $55.00 in a research note on Tuesday, January 21st. Mizuho lifted their price objective on shares of Genpact from $45.00 to $55.00 and gave the company a “neutral” rating in a research note on Monday, February 10th. Needham & Company LLC increased their target price on shares of Genpact from $55.00 to $65.00 and gave the company a “buy” rating in a research report on Friday, February 7th. Finally, TD Cowen upgraded shares of Genpact from a “hold” rating to a “buy” rating and boosted their price target for the stock from $45.00 to $60.00 in a research report on Friday, February 7th. Six analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $48.44.
View Our Latest Report on Genpact
Insider Transactions at Genpact
In other Genpact news, CEO Balkrishan Kalra sold 13,600 shares of the firm’s stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $48.89, for a total value of $664,904.00. Following the completion of the transaction, the chief executive officer now directly owns 310,246 shares in the company, valued at $15,167,926.94. This trade represents a 4.20 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. 2.80% of the stock is owned by insiders.
Genpact Company Profile
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Further Reading
- Five stocks we like better than Genpact
- 3 Stocks to Consider Buying in October
- Viking Therapeutics Stock Pops But Struggles to Hold Gains
- There Are Different Types of Stock To Invest In
- Qualcomm Stock Just Earned a Fresh Buy Rating—Get Excited
- Want to Profit on the Downtrend? Downtrends, Explained.
- Meta Stock Holds Upside Potential as Analysts Cut Price Targets
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.